Wistar Wire: Melanoma

Ben Leach
Wistar scientists have published new studies on fundamental aspects of melanoma metastasis and therapy resistance, the application of a novel immunotherapeutic technology to prevent infection with antibiotic-resistant bacteria, and the discovery of new aspects of the three-dimensional organization of the genome. Also, the National Institutes of Health (NIH) selected a Wistar principal investigator for her innovative epigenetics research.
Ben Leach
(l to r) Richard Horowitz, Adele Schaeffer, Helen Pudlin, Dario Altieri
(l to r) Richard Horowitz, Adele Schaeffer, Helen Pudlin, Dario Altieri
Donors, supporters, scientists and friends gathered for a black-tie gala at Dilworth Park at Philadelphia’s City Hall to honor Wistar’s illustrious history of scientific achievements and board president Helen P. Pudlin, Esq..
Ben Leach
A new study from Wistar scientists has demonstrated a potential method for treating an aggressive type of ovarian cancer. A young scientist was honored for her melanoma research paper, while another traveled to Singapore to present new data about a Zika vaccine.
Awards, Cancer, Melanoma
Ben Leach
Recent studies from Wistar scientists have demonstrated new methods that could provide more effective ways of fighting the flu and cancer. Two scientists were also honored with awards for their work on melanoma.